CYCLOPHOSPHAMIDE VERSUS IFOSFAMIDE - FINAL REPORT OF A RANDOMIZED PHASE-II TRIAL IN ADULT SOFT-TISSUE SARCOMAS

被引：232
|
作者：
BRAMWELL, VHC
MOURIDSEN, HT
SANTORO, A
BLACKLEDGE, G
SOMERS, R
VERWEY, J
DOMBERNOWSKY, P
ONSRUD, M
THOMAS, D
SYLVESTER, R
VANOOSTEROM, A
机构：
[1] CHRISTIE HOSP & HOLT RADIUM INST,MANCHESTER M20 9BX,LANCS,ENGLAND
[2] FINSEN INST,DK-2100 COPENHAGEN O,DENMARK
[3] INST NAZ DEI TUMORI,MILAN,ITALY
[4] QUEEN ELIZABETH HOSP,BIRMINGHAM B15 2TH,W MIDLANDS,ENGLAND
[5] ANTONI VANLEEUWENHOEK HOSP,AMSTERDAM,NETHERLANDS
[6] ROTTERDAM RADIOTHERAPEUT INST,ROTTERDAM,NETHERLANDS
[7] HERLEV HOSP,DK-2730 HERLEV,DENMARK
[8] DER NORSKE RADIUM HOSP,OSLO,NORWAY
[9] EORTC DATA CTR,BRUSSELS,BELGIUM
[10] AKAD ZIEKENHUIS,LEIDEN,NETHERLANDS
来源：
EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY | 1987年 / 23卷 / 03期
关键词：
D O I：
10.1016/0277-5379(87)90075-7
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：311 / 321
页数：11
相关论文
共 50 条
  • [41] PHASE-II STUDY OF NIMUSTINE IN METASTATIC SOFT-TISSUE SARCOMA
    WAGENER, DJT
    SOMERS, R
    SANTORO, A
    VERWEIJ, J
    WOLL, PJ
    BLACKLEDGE, G
    SCHUTTE, HJ
    LENTZ, MA
    VANGLABBEKE, M
    EUROPEAN JOURNAL OF CANCER, 1991, 27 (12) : 1604 - 1605
  • [42] A randomised phase II trial of selumetinib vs selumetinib plus temsirolimus for soft-tissue sarcomas
    Eroglu, Z.
    Tawbi, H. A.
    Hu, J.
    Guan, M.
    Frankel, P. H.
    Ruel, N. H.
    Wilczynski, S.
    Christensen, S.
    Gandara, D. R.
    Chow, W. A.
    BRITISH JOURNAL OF CANCER, 2015, 112 (10) : 1644 - 1651
  • [43] PHASE-II STUDY OF ELLIPTINIUM IN METASTATIC SOFT-TISSUE SARCOMA
    SOMERS, R
    ROUESSE, J
    VANOOSTEROM, A
    THOMAS, D
    EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1985, 21 (05): : 591 - 593
  • [44] PHASE-II STUDY OF EPIRUBICIN IN ADVANCED SOFT-TISSUE SARCOMA
    CHEVALLIER, B
    MONTCUQUET, P
    FACHINI, T
    BUI, BN
    KERBRAT, P
    BASTIT, P
    VAN, MV
    BULLETIN DU CANCER, 1990, 77 (10) : 991 - 995
  • [45] A randomised phase II trial of selumetinib vs selumetinib plus temsirolimus for soft-tissue sarcomas
    Z Eroglu
    H A Tawbi
    J Hu
    M Guan
    P H Frankel
    N H Ruel
    S Wilczynski
    S Christensen
    D R Gandara
    W A Chow
    British Journal of Cancer, 2015, 112 : 1644 - 1651
  • [46] A PHASE I-II STUDY OF IFOSFAMIDE IN COMBINATION WITH ADRIAMYCIN IN THE TREATMENT OF ADULT SOFT-TISSUE SARCOMA
    MANSI, JL
    MACMILLAN, S
    FISHER, C
    WILTSHAW, E
    BRITISH JOURNAL OF CANCER, 1988, 58 (02) : 249 - 249
  • [47] A PHASE-I-II STUDY OF IFOSFAMIDE IN COMBINATION WITH ADRIAMYCIN IN THE TREATMENT OF ADULT SOFT-TISSUE SARCOMA
    MANSI, JL
    FISHER, C
    WILTSHAW, E
    MACMILLAN, S
    KING, M
    STUARTHARRIS, R
    EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1988, 24 (09): : 1439 - 1443
  • [48] RANDOMIZED COMPARISON OF DOXORUBICIN ALONE VERSUS IFOSFAMIDE PLUS DOXORUBICIN OR MITOMYCIN, DOXORUBICIN, AND CISPLATIN AGAINST ADVANCED SOFT-TISSUE SARCOMAS
    EDMONSON, JH
    RYAN, LM
    BLUM, RH
    BROOKS, JSJ
    SHIRAKI, M
    FRYTAK, S
    PARKINSON, DR
    JOURNAL OF CLINICAL ONCOLOGY, 1993, 11 (07) : 1269 - 1275
  • [49] Gemcitabine in advanced adult soft-tissue sarcomas.: A phase II study of the EORTC Soft Tissue and Bone Sarcoma Group
    Svancárová, L
    Blay, JY
    Judson, IR
    van Hoesel, QGCM
    van Oosterom, AT
    le Cesne, A
    Keizer, HJ
    Hermans, C
    van Glabbeke, M
    Verweij, J
    Hogendoorn, PCW
    Nielsen, OS
    EUROPEAN JOURNAL OF CANCER, 2002, 38 (04) : 556 - 559
  • [50] Cyclophosphamide versus ifosfamide for paediatric and young adult bone and soft tissue sarcoma patients
    Mulder, Renee L.
    Paulides, Marios
    Langer, Thorsten
    Kremer, Leontien C. M.
    van Dalen, Elvira C.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2010, (02):
12345